The authors developed third-generation anti-CD123 CAR T cells with a humanized CSL362-based ScFv and a CD28-OX40-CD3ζ intracellular signaling domain.
[Nature Communications]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.